Common complications in spinal muscular atrophy (SMA) type 1 after nusinersen treatment

Common complications in spinal muscular atrophy (SMA) type 1 after nusinersen treatment

Background. Spinal muscular atrophy (SMA) is an inherited disease with progressive muscle weakness and atrophy. Despite the new treatments developed recently, primary and secondary effects of muscle weakness in patients with SMA cause mortality and morbidity. The aim of this study is to identify co...

Full description

Saved in:
Bibliographic Details
Main Authors: Yiğithan Güzin, Osman Büyükşen, Pınar Gençpınar, Nihal Olgaç Dündar, Figen Baydan
Format: Article
Language:English
Published: Hacettepe University Institute of Child Health 2024-11-01
Series:The Turkish Journal of Pediatrics
Subjects:
Spinal muscular atrophy type 1
mortality
morbidity
nusinersen
SMN1
Online Access:https://turkjpediatr.org/article/view/4527
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items